Literature DB >> 3941271

In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.

P Q Patek, Y Lin, J L Collins, M Cohn.   

Abstract

Experiments were designed to test the hypothesis that transformed cells that are NC sensitive must escape NC activity if they are to grow as tumors in normal individuals. NC-resistant variants were selected either in vivo or in vitro from NC-sensitive cell lines that grow as tumors in immunodeficient mice but not in syngeneic normal mice. The tumorigenicity of cloned NC-resistant variants was compared with the parental cell lines and to cell lines that went through the selection procedure, but after cloning remained NC sensitive. Cloned NC-resistant cell lines derived from tumors that developed in x-irradiated nude mice after the injection of an NC-sensitive cell line are tumorigenic in normal mice, whereas cloned NC-sensitive cell lines derived from the same tumors are unable to grow as tumors in normal mice. Similarly, six of seven NC-resistant cloned cell lines independently isolated after in vitro selection for NC-resistance are tumorigenic in normal mice, whereas cloned NC-sensitive cell lines isolated from the same in vitro selected populations are not tumorigenic in normal mice. Thus, either the in vivo or in vitro selection of NC-resistant cells selects for cells tumorigenic in normal mice; these findings, along with our previous observations that selection for cells tumorigenic in normal mice selects for NC resistance, provide compelling evidence that escape from NC activity is required before some transformed cells can grow as tumors in normal mice.

Entities:  

Mesh:

Year:  1986        PMID: 3941271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor.

Authors:  Y Lin; P G Case; P Q Patek
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

2.  Antitumor immune surveillance by tumor necrosis factor producing cells.

Authors:  E C Lattime; O Stutman
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.

Authors:  C B Powell; D G Mutch; M S Kao; J L Collins
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

Authors:  J L Collins; M S Kao
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Natural cytotoxic activity is not necessarily mediated by the release of tumour necrosis factor.

Authors:  P Q Patek; Y Lin
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

6.  Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cells.

Authors:  H Pelletier; N O Olsson; C Fady; D Reisser; P Lagadec; J F Jeannin
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapy.

Authors:  K Satoh; N Kan; T Okino; M Nakanishi; K Mise; Y Teramura; S Yamasaki; K Ohgaki; T Tobe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.